source
- Novo Nordisk leads early in oral obesity market, but analysts doubt lasting advantageNovo Nordisk's oral formulation of Wegovy generated DKK 3.22 billion (about $496 million) in revenue in the second quarter of 2026, far outpacing Eli Lilly's newly approved oral weight‑loss pill Fo…
- Trump administration nominates Heidi Overton as FDA commissionerPresident Donald Trump has nominated Heidi Overton, the White House deputy director of domestic policy, to serve as the next commissioner of the Food and Drug Administration. Overton has been desc…